Seeing Is Believing
Healthcare - Sector
HALO is currently covered by 10 analysts with an average price target of $81.43. This is a potential upside of -$28.99 (-26.25%) from yesterday's end of day stock price of $110.42.
Halozyme Therapeutics's activity chart (see below) currently has 316 price targets and 242 ratings on display. The stock rating distribution of HALO is 3.45% SELL, 79.31% BUY and 17.24% HOLD.
Analysts average stock forecasts to be materialized ratio is 85.08% with an average time for these price targets to be met of 235.09 days.
Highest price target for HALO is $115, Lowest price target is $56, average price target is $81.43.
Most recent stock forecast was given by JESSICA FYE from JPMORGAN. First documented stock forecast 29-Apr-2014.
Currently out of the existing stock ratings of HALO, 1 are a SELL (3.45%), 23 are a BUY (79.31%), 5 are a HOLD (17.24%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Apr-2025
$78
$-32.42 (-29.36%)
$65
Buy Since 24-Jul-2023
$115
$4.58 (4.15%)
$115
1 months 10 days ago
(02-Sep-2026)
46/46 (100%)
$5.34 (4.87%)
176
Buy Since 29-Feb-2024
$105
$-5.42 (-4.91%)
$96
2 months 5 days ago
(07-Aug-2026)
12/12 (100%)
$1.88 (1.82%)
168
Buy Since 27-Nov-2018
$93
$-17.42 (-15.78%)
$92
2 months 5 days ago
(07-Aug-2026)
18/19 (94.74%)
$-10.12 (-9.81%)
366
Hold Since 13-Jan-2025
$95
$-15.42 (-13.96%)
$75
2 months 5 days ago
(07-Aug-2026)
10/11 (90.91%)
$-8.12 (-7.87%)
288
What is HALO (Halozyme Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on HALO (Halozyme Therapeutics)?
Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?
Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?
Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?